[Risk Factors Analysis of Thromboembolism in Patients with Lymphoma Chemotherapy].

Objective: To evaluate the risk factors affecting thromboembolism in lymphoma patients with chemotherapy.

Methods: Three hundred and four consecutive lymphoma patients treated by chemotherapy between January 2012 and July 2019 were enrolled and retrospectively analyzed, consisting of 111 patients with thromboembolism and 193 without thromboembolism. Univariate analysis was used to compare the clinical characteristics and related laboratory examination between the patients, while multivariate Logistic regression analysis were used to identify the risk factors affecting thromboembolism in lymphoma patients with chemotherapy.